Journal of Vascular and Interventional Radiology最新文献

{"title":"The International Symposium on Endovascular Therapy (ISET) 2025","authors":"","doi":"10.1016/j.jvir.2024.12.006","DOIUrl":"10.1016/j.jvir.2024.12.006","url":null,"abstract":"","PeriodicalId":49962,"journal":{"name":"Journal of Vascular and Interventional Radiology","volume":"36 2","pages":"Pages e1-e25"},"PeriodicalIF":2.6,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143170499","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Radiation Pneumonitis after Yttrium-90 Radioembolization: A Systematic Review","authors":"Bela Kis MD, PhD ,&nbsp;Marcell Gyano MD, PhD","doi":"10.1016/j.jvir.2024.08.031","DOIUrl":"10.1016/j.jvir.2024.08.031","url":null,"abstract":"<div><h3>Purpose</h3><div>To evaluate the available evidence of lung dosimetry and radiation pneumonitis (RP).</div></div><div><h3>Materials and Methods</h3><div>The guideline regarding the maximum tolerated lung dose for yttrium-90 (⁹⁰Y) radioembolization is an expert opinion (Level 5 evidence) based on a case series of 5 patients and recommends keeping the absorbed radiation dose to the lungs below 30 Gy per treatment and 50 Gy in a lifetime to prevent RP. The current understanding of the risks of RP is minimal despite its debilitating nature and high mortality rate. A systematic literature review was conducted in PubMed, Embase, Cochrane database, and Google Scholar for reported cases of RP. A database of 48 RP cases was compiled and analyzed.</div></div><div><h3>Results</h3><div>Thirty patients were treated with resin and 16 patients with glass ⁹⁰Y microspheres. The treatment device was not reported in 2 cases. RP developed a median of 3 months after radioembolization. The mortality rate was 40%. The hepatopulmonary shunt was not significantly different between the glass and the resin groups (21.2% [SD ± 14%] vs 15.6% [SD ± 7.5%]; <em>P</em> = .24). The radiation dose to the lungs was significantly higher in patients treated with glass compared with those with resin ⁹⁰Y microspheres (41.4 Gy [SD ± 18.4] vs 21.5 Gy [SD ± 9.9]; <em>P</em> = .003).</div></div><div><h3>Conclusions</h3><div>The dose toxicity threshold for resin microspheres is lower than that of glass microspheres. The established 30-Gy dose limit may not be uniformly applicable in all cases and for both devices. The maximum tolerable lung doses should be reevaluated, and the shortcomings of the hepatopulmonary shunt calculation need to be corrected.</div></div>","PeriodicalId":49962,"journal":{"name":"Journal of Vascular and Interventional Radiology","volume":"36 2","pages":"Pages 207-218"},"PeriodicalIF":2.6,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142479262","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Commentary: Bowel and Stomach Resilience to Cryoablation Injury","authors":"Eric M. Mastria MD, PhD","doi":"10.1016/j.jvir.2024.10.022","DOIUrl":"10.1016/j.jvir.2024.10.022","url":null,"abstract":"","PeriodicalId":49962,"journal":{"name":"Journal of Vascular and Interventional Radiology","volume":"36 2","pages":"Pages 264-265"},"PeriodicalIF":2.6,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142568885","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Comparison of Covered Stent versus Bare-Metal Stent Implantation in Aortoiliac Occlusive Disease: A Systematic Review and Meta-Analysis","authors":"Sheng Fang MD,&nbsp;Min Zhou PhD,&nbsp;Xu Li PhD,&nbsp;Yong Ding PhD,&nbsp;Tianchen Xie MD,&nbsp;Zhenyu Zhou PhD,&nbsp;Zhenyu Shi MD, PhD","doi":"10.1016/j.jvir.2024.10.035","DOIUrl":"10.1016/j.jvir.2024.10.035","url":null,"abstract":"<div><h3>Purpose</h3><div>This systematic review aimed to compare covered stent (CS) and bare-metal stent (BMS) implantation in treating aortoiliac occlusive disease.</div></div><div><h3>Materials and Methods</h3><div>Comprehensive searches were conducted in the MEDLINE, Embase, and Cochrane Library databases for all pertinent studies. The end points included primary patency, secondary patency, freedom from target lesion revascularization (TLR), technical success, ankle-brachial index (ABI) improvement, periprocedural adverse events, major amputation, and mortality. Odds ratios (OR) or risk differences with 95% CIs were used to estimate the binary variables. The continuous variables were presented as mean difference (MD) with 95% CI.</div></div><div><h3>Results</h3><div>Ten studies involving 1,861 limbs were included. For overall outcomes, compared with BMS, CS showed significantly superior in freedom from TLR (OR, 3.00; 95% CI, 1.05–8.51; <em>P</em> = .04) and ABI (MD, 0.03; 95% CI, −0.00 to 0.06; <em>P</em> = .04). No significant differences were found in technical success, primary patency (at 12, 24, 36, and 60 months), secondary patency, periprocedural adverse events, major amputation rates, and early mortality. Subgroup analyses favored CS in ABI improvement (MD, 0.06; 95% CI, 0.02–0.11; <em>P</em> = .01) after propensity score matching, and covered balloon-expandable stents demonstrated certain advantages in freedom from TLR (OR, 4.60; 95% CI, 1.79–11.81; <em>P</em> = .002). Additionally, no significant difference in primary patency at 36 months between the 2 groups with Trans-Atlantic Inter-Society Consensus D or severe calcification lesions.</div></div><div><h3>Conclusions</h3><div>Compared with BMS, CS presented advantages in reducing TLR and enhancing ABI improvement. Meanwhile, CS demonstrated comparable technical success, primary patency, secondary patency, periprocedural adverse events, major amputation rates, and early mortality.</div></div>","PeriodicalId":49962,"journal":{"name":"Journal of Vascular and Interventional Radiology","volume":"36 2","pages":"Pages 237-246.e9"},"PeriodicalIF":2.6,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142631674","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Outcomes of Transarterial Embolization in Patients with Isolated Pelvic Fractures: A Japanese Nationwide Study Focused on Shock Status and Age","authors":"Kosuke Otake MD, PhD ,&nbsp;Takashi Tagami MD, MPH, PhD ,&nbsp;Chie Tanaka MD, PhD ,&nbsp;Yudai Yoshino MD ,&nbsp;Akihiro Watanabe MD, PhD ,&nbsp;Ami Shibata MD, PhD ,&nbsp;Kentaro Kuwamoto MD ,&nbsp;Junichi Inoue MD, PhD ,&nbsp;Shoji Yokobori MD, PhD","doi":"10.1016/j.jvir.2024.10.032","DOIUrl":"10.1016/j.jvir.2024.10.032","url":null,"abstract":"<div><h3>Purpose</h3><div>To investigate the effect of transarterial embolization (TAE) on the 30-day survival of patients with isolated pelvic fractures, focusing on the influence of shock status and age.</div></div><div><h3>Materials and Methods</h3><div>This retrospective cohort study used data from the Japan Trauma Data Bank (2004–2018). Patients with isolated pelvic fractures, defined by an Abbreviated Injury Scale score of ≥3, were included. Shock (shock index, ≥1) and nonshock (shock index, &lt;1) were grouped. Inverse probability weighting using propensity scores was performed to adjust for the confounding factors. The primary outcome measure was the 30-day in-hospital mortality. The 30-day survival was compared by age groups: 0–19 years, 20–39 years, 40–59 years, 60–79 years, and ≥80 years.</div></div><div><h3>Results</h3><div>Of the 5,025 eligible patients, 866 presented with shock, and 4,159 served as the nonshock group. The propensity score analysis showed that there was no significant difference in survival between the TAE and non-TAE groups in patients without shock (TAE group vs non-TAE group, 92.4% vs 92.5%; risk difference, −0.05%; 95% CI, −0.5% to 0.4%). Conversely, for patients with shock, the TAE group had a significantly higher 30-day survival rate than the non-TAE group (83.0% vs 76.2%; risk difference, 6.7%; 95% CI, 5.1%–8.3%). Among the age groups, the risk difference was highest in the ≥80 years age group (78.5% vs 66.6%; risk difference, 11.9%; 95% CI, 7.7%–16.1%).</div></div><div><h3>Conclusions</h3><div>This nationwide study suggested that provision of TAE was associated with improved 30-day survival in patients with isolated pelvic fractures and shock, particularly for those aged ≥80 years.</div></div>","PeriodicalId":49962,"journal":{"name":"Journal of Vascular and Interventional Radiology","volume":"36 2","pages":"Pages 310-317.e1"},"PeriodicalIF":2.6,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142631685","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Yttrium-90 Radioembolization Has Become the Most Utilized Bridging Treatment for Liver Transplant Candidates in the United States","authors":"Riad Salem MD, MBA ,&nbsp;Allison J. Kwong MD ,&nbsp;Nathan Kim MD ,&nbsp;Daniel Y. Sze MD, PhD ,&nbsp;Neil Mehta MD","doi":"10.1016/j.jvir.2024.10.034","DOIUrl":"10.1016/j.jvir.2024.10.034","url":null,"abstract":"","PeriodicalId":49962,"journal":{"name":"Journal of Vascular and Interventional Radiology","volume":"36 2","pages":"Pages 362-363"},"PeriodicalIF":2.6,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142631741","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Contents in Brief","authors":"","doi":"10.1016/S1051-0443(24)00795-4","DOIUrl":"10.1016/S1051-0443(24)00795-4","url":null,"abstract":"","PeriodicalId":49962,"journal":{"name":"Journal of Vascular and Interventional Radiology","volume":"36 2","pages":"Page A4"},"PeriodicalIF":2.6,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143169240","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Crossword Puzzle: Answer Key","authors":"","doi":"10.1016/j.jvir.2024.11.009","DOIUrl":"10.1016/j.jvir.2024.11.009","url":null,"abstract":"","PeriodicalId":49962,"journal":{"name":"Journal of Vascular and Interventional Radiology","volume":"36 2","pages":"Page 372"},"PeriodicalIF":2.6,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143170498","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Percutaneous Ablation vs Radiotherapy for Pain Related to Bone and Soft Tissue Malignancies: A Multi-Payor Database Analysis of Outcomes.","authors":"Will S Lindquester, Jay Shah, Eric Friedberg, Michal Horný, John David Prologo","doi":"10.1016/j.jvir.2025.01.045","DOIUrl":"https://doi.org/10.1016/j.jvir.2025.01.045","url":null,"abstract":"<p><strong>Purpose: </strong>The purpose of this study was to compare key hospitalization outcomes and cost between percutaneous ablation and external beam radiation therapy (EBRT) among patients admitted with acute cancer-related pain.</p><p><strong>Materials and methods: </strong>The Merative MarketScan Research Database was queried for all cancer-related hospitalizations from 2009 to 2022 for patients who underwent percutaneous palliative ablation or EBRT for painful bone or soft tissue tumors. Hospital length of stay (LOS), 30-day readmission rate, in-hospital mortality, and total hospitalization costs from the payor perspective were compared using multivariable generalized linear models controlling for patient demographics, comorbid conditions, geographic location, and calendar year. Sensitivity analyses were conducted using different model specifications and coarsened exact matching.</p><p><strong>Results: </strong>Amongst 19,793 hospitalizations, patients underwent ablation in 185 (0.9%) cases, and EBRT in 19,608 (99.1%). Compared to EBRT, ablation was associated with shorter LOS (-2.0 days; 95% confidence interval [CI]: -3.9 to -0.03; p = .046), lower risk of in-hospital mortality (-3.4 percentage points [p.p.]; 95% CI: -5.6 to -1.3; p = .002), lower risk of 30-day readmission (-7.4 p.p.; 95% CI: -13.7 to -1.2; p = .019), and no statistically significant difference in total hospitalization costs ($8,379; 95% CI: -1,947 to 18,706; p = .11).</p><p><strong>Conclusions: </strong>Less than 1% of patients hospitalized with acute cancer-related pain and treated with tumor-directed therapy (either via radiation oncology or IR) undergo percutaneous tumor ablation. In this study, percutaneous ablation was associated with shorter LOS, lower risk of in-hospital mortality, and lower risk of 30-day readmission.</p>","PeriodicalId":49962,"journal":{"name":"Journal of Vascular and Interventional Radiology","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2025-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143076266","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Assessment of Catheter-Directed Thrombolysis and Histotripsy Treatment for Deep Vein Thrombosis.","authors":"Kevin Zhao, Erik Saucedo, Katia Flores Basterreachea, Shumeng Yang, Kevin J Haworth, Christy K Holland, John M Racadio, Adam D Maxwell, John F Cursio, Geoffrey D Wool, Allison M Ostdiek, Osman S Ahmed, Jonathan D Paul, Mikin V Patel, Kenneth B Bader","doi":"10.1016/j.jvir.2025.01.044","DOIUrl":"https://doi.org/10.1016/j.jvir.2025.01.044","url":null,"abstract":"<p><strong>Purpose: </strong>The hypothesis of this study was histotripsy, an ultrasound therapy that disrupts tissue mechanically through the action of bubble clouds, increases the short-term rate of acute thrombus clearance for catheter-directed thrombolysis (CDT) in an animal model.</p><p><strong>Materials and methods: </strong>Thrombi formed in the femoral vein of pigs were treated with CDT, histotripsy, or CDT and histotripsy (histotripsy+). Ultrasound (B-mode and color Doppler) and contrast fluoroscopy imaging data were scored by four observers for semi-quantitative evaluation of each arm with ordinal regression models. Further, B-mode images were manually annotated by three observers to quantify the thrombus clearance rate.</p><p><strong>Results: </strong>A total of 27 thrombi (2.0 ± 0.4 cm in length) in 27 animals were considered in this study (N = 8 for CDT, N = 9 for histotripsy, and N = 10 for histotripsy+). The mean treatment duration was 20.2 ± 1.3 min. The ordinal regression models indicated the thrombus clearance rate was increased for histotripsy+ relative to CDT based on B-mode and color Doppler, but not fluoroscopy (p = 0.015, 0.001, and 0.900, respectively). Manual annotation of B-mode images denoted histotripsy+ had an increased thrombus clearance rate relative to CDT and histotripsy (p = 0.001 and 0.022, respectively). Petechial hemorrhage was present in the perivascular soft tissue for two cases with histotripsy and one case with histotripsy+.</p><p><strong>Conclusions: </strong>The clearance of acute thrombus was similar for treatment with CDT or histotripsy. Combining these individual approaches further increased the rate of thrombus clearance based on multiple imaging metrics.</p>","PeriodicalId":49962,"journal":{"name":"Journal of Vascular and Interventional Radiology","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2025-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143076265","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}